...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics

under symbol ZHCLF is definitely trading, even though it is in the grey market.  Zenith Epigenetics has not IPO'd yet, but my bet is that McCaffrey will be doing it very soon.  The deal with NCI created a platform for their molecule.  That is what Big Pharma wants to buy.  ZHCLF has stated in its own web site that as of June 2020 the company is worth $1 US.  Therefore, with investors expecting an imminent IPO, if you can get shares for .08, .20, or like yesterday .53 seems like a bargain.  The grey market activity suggests that the IPO announcement or a Buyout is going to be sooner rather than later.

Hang onto your shares.  I am in the United States.

Share
New Message
Please login to post a reply